Arkolith/Insider Trading/TNYA/Form 4

Tingley Whittemore

Chief Medical OfficerTenaya Therapeutics, Inc. (TNYA) · full profile →Form 4 · filed Jan 28, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 24, 2025Grant(A)40K—$0147K
Jan 24, 2025Grant(A)32K—$0179K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 24, 2025Disposed to issuer(D)215K——0
Jan 24, 2025Disposed to issuer(D)70K——0
Jan 24, 2025Grant(A)235K—$0235K
Jan 24, 2025Grant(A)205K——205K
Jan 24, 2025Disposed to issuer(D)205K——0
Jan 24, 2025Grant(A)141K——141K
Jan 24, 2025Disposed to issuer(D)141K——0
Jan 24, 2025Grant(A)70K——70K
Jan 24, 2025Grant(A)215K——215K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-010075) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML